A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Novartis
Novartis
Hutchmed
Servier
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Eli Lilly and Company
ABM Therapeutics Corporation
Quadriga Biosciences, Inc.